Cargando…

Diagnostic performance of contrast enhanced CT and (18)F-FDG PET/CT in suspicious recurrence of biliary tract cancer after curative resection

BACKGROUND: Because of the late clinical presentation of biliary tract cancer (BTC), only 10% of patients are eligible for curative surgery. Even among those patients who have undergone curative surgery, most patients develop recurrent cancer. This study is to determine the clinical role of (18)F-FD...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yun-Gyoo, Han, Sae-Won, Oh, Do-Youn, Chie, Eui Kyu, Jang, Jin-Young, Im, Seock-Ah, Kim, Tae-You, Kim, Sun-Whe, Ha, Sung Whan, Bang, Yung-Jue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120804/
https://www.ncbi.nlm.nih.gov/pubmed/21599995
http://dx.doi.org/10.1186/1471-2407-11-188
_version_ 1782206760319188992
author Lee, Yun-Gyoo
Han, Sae-Won
Oh, Do-Youn
Chie, Eui Kyu
Jang, Jin-Young
Im, Seock-Ah
Kim, Tae-You
Kim, Sun-Whe
Ha, Sung Whan
Bang, Yung-Jue
author_facet Lee, Yun-Gyoo
Han, Sae-Won
Oh, Do-Youn
Chie, Eui Kyu
Jang, Jin-Young
Im, Seock-Ah
Kim, Tae-You
Kim, Sun-Whe
Ha, Sung Whan
Bang, Yung-Jue
author_sort Lee, Yun-Gyoo
collection PubMed
description BACKGROUND: Because of the late clinical presentation of biliary tract cancer (BTC), only 10% of patients are eligible for curative surgery. Even among those patients who have undergone curative surgery, most patients develop recurrent cancer. This study is to determine the clinical role of (18)F-FDG PET/CT during post-operative surveillance of suspected recurrent BTC based on symptoms, laboratory findings and contrast-enhanced CT (ceCT) findings. METHODS: We consecutively enrolled 50 patients with BTC who underwent curative surgery. An (18)F-FDG PET/CT was obtained for assessment of recurrence based on clinical suspicion during post-operative surveillance. The final confirmation of recurrence was determined pathologically or clinically. When a pathologic confirmation was impossible or inconclusive, a clinical confirmation was used by radiologic correlation with subsequent follow-up ceCT at a minimum of 3-month intervals. Diagnostic efficacy was evaluated by comparing the results of ceCT and (18)F-FDG PET/CT with the final diagnosis. RESULTS: Among the 50 patients, 34(68%) were confirmed to have a recurrence. PET/CT showed higher sensitivity (88% vs. 76%, p = 0.16) and accuracy (82% vs. 66%, p = 0.11) for recurrence compared to ceCT, even though the difference was not significant. The positive (86% vs. 74%, p = 0.72) and negative predictive values for recurrence (73% vs. 47%, p = 0.55) were not significantly different between PET/CT and ceCT. However, an additional PET/CT on ceCT significantly improved the sensitivity than did a ceCT alone (94% [32/34] for PET/CT on ceCT vs. 76% [26/34] for ceCT alone, p = 0.03) without increasing the specificity, positive predictive value, and negative predictive value. CONCLUSIONS: (18)F-FDG PET/CT alone is not more sensitive or specific than ceCT in the detection of recurrent BTC after curative surgery. These results do not reach statistical significance, probably due to the low number of patients. However, an additional (18)F-FDG PET/CT on ceCT significantly improves the sensitivity of detecting recurrences.
format Online
Article
Text
id pubmed-3120804
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31208042011-06-23 Diagnostic performance of contrast enhanced CT and (18)F-FDG PET/CT in suspicious recurrence of biliary tract cancer after curative resection Lee, Yun-Gyoo Han, Sae-Won Oh, Do-Youn Chie, Eui Kyu Jang, Jin-Young Im, Seock-Ah Kim, Tae-You Kim, Sun-Whe Ha, Sung Whan Bang, Yung-Jue BMC Cancer Research Article BACKGROUND: Because of the late clinical presentation of biliary tract cancer (BTC), only 10% of patients are eligible for curative surgery. Even among those patients who have undergone curative surgery, most patients develop recurrent cancer. This study is to determine the clinical role of (18)F-FDG PET/CT during post-operative surveillance of suspected recurrent BTC based on symptoms, laboratory findings and contrast-enhanced CT (ceCT) findings. METHODS: We consecutively enrolled 50 patients with BTC who underwent curative surgery. An (18)F-FDG PET/CT was obtained for assessment of recurrence based on clinical suspicion during post-operative surveillance. The final confirmation of recurrence was determined pathologically or clinically. When a pathologic confirmation was impossible or inconclusive, a clinical confirmation was used by radiologic correlation with subsequent follow-up ceCT at a minimum of 3-month intervals. Diagnostic efficacy was evaluated by comparing the results of ceCT and (18)F-FDG PET/CT with the final diagnosis. RESULTS: Among the 50 patients, 34(68%) were confirmed to have a recurrence. PET/CT showed higher sensitivity (88% vs. 76%, p = 0.16) and accuracy (82% vs. 66%, p = 0.11) for recurrence compared to ceCT, even though the difference was not significant. The positive (86% vs. 74%, p = 0.72) and negative predictive values for recurrence (73% vs. 47%, p = 0.55) were not significantly different between PET/CT and ceCT. However, an additional PET/CT on ceCT significantly improved the sensitivity than did a ceCT alone (94% [32/34] for PET/CT on ceCT vs. 76% [26/34] for ceCT alone, p = 0.03) without increasing the specificity, positive predictive value, and negative predictive value. CONCLUSIONS: (18)F-FDG PET/CT alone is not more sensitive or specific than ceCT in the detection of recurrent BTC after curative surgery. These results do not reach statistical significance, probably due to the low number of patients. However, an additional (18)F-FDG PET/CT on ceCT significantly improves the sensitivity of detecting recurrences. BioMed Central 2011-05-21 /pmc/articles/PMC3120804/ /pubmed/21599995 http://dx.doi.org/10.1186/1471-2407-11-188 Text en Copyright ©2011 Lee et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Lee, Yun-Gyoo
Han, Sae-Won
Oh, Do-Youn
Chie, Eui Kyu
Jang, Jin-Young
Im, Seock-Ah
Kim, Tae-You
Kim, Sun-Whe
Ha, Sung Whan
Bang, Yung-Jue
Diagnostic performance of contrast enhanced CT and (18)F-FDG PET/CT in suspicious recurrence of biliary tract cancer after curative resection
title Diagnostic performance of contrast enhanced CT and (18)F-FDG PET/CT in suspicious recurrence of biliary tract cancer after curative resection
title_full Diagnostic performance of contrast enhanced CT and (18)F-FDG PET/CT in suspicious recurrence of biliary tract cancer after curative resection
title_fullStr Diagnostic performance of contrast enhanced CT and (18)F-FDG PET/CT in suspicious recurrence of biliary tract cancer after curative resection
title_full_unstemmed Diagnostic performance of contrast enhanced CT and (18)F-FDG PET/CT in suspicious recurrence of biliary tract cancer after curative resection
title_short Diagnostic performance of contrast enhanced CT and (18)F-FDG PET/CT in suspicious recurrence of biliary tract cancer after curative resection
title_sort diagnostic performance of contrast enhanced ct and (18)f-fdg pet/ct in suspicious recurrence of biliary tract cancer after curative resection
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120804/
https://www.ncbi.nlm.nih.gov/pubmed/21599995
http://dx.doi.org/10.1186/1471-2407-11-188
work_keys_str_mv AT leeyungyoo diagnosticperformanceofcontrastenhancedctand18ffdgpetctinsuspiciousrecurrenceofbiliarytractcanceraftercurativeresection
AT hansaewon diagnosticperformanceofcontrastenhancedctand18ffdgpetctinsuspiciousrecurrenceofbiliarytractcanceraftercurativeresection
AT ohdoyoun diagnosticperformanceofcontrastenhancedctand18ffdgpetctinsuspiciousrecurrenceofbiliarytractcanceraftercurativeresection
AT chieeuikyu diagnosticperformanceofcontrastenhancedctand18ffdgpetctinsuspiciousrecurrenceofbiliarytractcanceraftercurativeresection
AT jangjinyoung diagnosticperformanceofcontrastenhancedctand18ffdgpetctinsuspiciousrecurrenceofbiliarytractcanceraftercurativeresection
AT imseockah diagnosticperformanceofcontrastenhancedctand18ffdgpetctinsuspiciousrecurrenceofbiliarytractcanceraftercurativeresection
AT kimtaeyou diagnosticperformanceofcontrastenhancedctand18ffdgpetctinsuspiciousrecurrenceofbiliarytractcanceraftercurativeresection
AT kimsunwhe diagnosticperformanceofcontrastenhancedctand18ffdgpetctinsuspiciousrecurrenceofbiliarytractcanceraftercurativeresection
AT hasungwhan diagnosticperformanceofcontrastenhancedctand18ffdgpetctinsuspiciousrecurrenceofbiliarytractcanceraftercurativeresection
AT bangyungjue diagnosticperformanceofcontrastenhancedctand18ffdgpetctinsuspiciousrecurrenceofbiliarytractcanceraftercurativeresection